Safety and Usage of an Amino Acid-based Formula for Infants: Results from a Post Market Surveillance Study.

Pamela Cekola1; Aimee Henrikson1; Heidi Reichert2; Sarah S Cohen2; Maureen B Huhmann1; Krysmaru
Araujo Torres1

Abstract

Safety and Usage of an Amino Acid-based Formula for Infants: Results from a Post Market Surveillance Study.

This prospective, multicenter, post-market surveillance program with Alfamino® Infant formula (HAA) was conducted during 2017-2018. Infants <12 months old were enrolled if the use of HAA was planned per their healthcare provider’s (HCP) recommendation, or if the infant was already consuming HAA at enrollment. Infants were followed by their HCP for routine care for four months.

Author(s):

Pamela Cekola1* , Aimee Henrikson1, Heidi Reichert2 , Sarah S Cohen2 , Maureen B Huhmann1 , Krysmaru
Araujo Torres1

Abstract | PDF

Share this